A recent comprehensive study reveals that 1 in 5 women in low- and middle-income countries grapple with perinatal anxiety disorders, shedding light on a critical yet often overlooked mental health challenge affecting maternal and infant outcomes in these regions.
A recent study unveils an association between residing in socioeconomically disadvantaged neighborhoods and heightened postpartum depression risk, particularly affecting Black individuals.
Explore the findings from a JAMA Network Open study, uncovering the stability of maternal depressive symptoms from pregnancy through 2 years postdelivery, highlighting a need for updated public health policies and timely interventions.
Discover the impact of air pollution on maternal mental health.
New research highlights the significant impact of posttraumatic stress disorder symptoms on the cardiovascular and neurocognitive health of midlife women.
New report shows worrying increase in burnout and harassment among employees.
The risk of depression after a traumatic brain injury was 48% greater in women than men when evaluated in a recent study discussed at the ANESTHESIOLOGY 2023 Annual Meeting.
In a recent study, overall and cervical-cancer specific deaths were more common among cervical cancer patients with a preexisting mental health disorder.
In a recent study, negative mental health symptoms such as increased anxiety were observed among combined oral contraceptive users when treatment was paused.
A recent study measuring sexual functioning in women with post-traumatic stress disorder was discussed at The Menopause Society 2023 Annual Meeting.
Results from a case study analysis submitted during the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois, highlight the potential of ketamine as a potential alternative to traditional antidepressants for postpartum depression (PPD) treatment.
In a recent study, adverse maternal and child outcomes associated with maternal postnatal depression were reduced by selective serotonin reuptake inhibitor use.
In a recent study, patients at risk of perinatal mood and anxiety disorders presented with different plasma protein levels than those not at risk.
In a recent survey, 23% of women reported hair thinning as the physical issue which brought them the most discomfort.
The first oral treatment for postpartum depression works in as little as 3 days and provides hope for women who suffer from this debilitating mental condition.
Survey finds stress levels for many are higher now than during height of the pandemic.
Survey results suggest more support for physicians would help.
Getting the number on the scale may do more harm than good, according to researchers.
Zuranolone (SAGE-217; SAGE Therapeutics) has been granted priority review for treatment against postpartum depression and major depressive disorder symptoms.
In a recent study, offspring were more likely to develop type 1 diabetes if they were born to mothers diagnosed with depression or anxiety during pregnancy.
In a recent study, being forced to travel out of state for abortion care led to increased feelings of worry, stigma, and being cast out among patients.
In a recent study, anxiety- and depression-related disorders were more common in women with polycystic ovary syndrome, chronic pelvic pain, and other reproductive disorders.
Research indicates that despite reports of high psychological stress among women in their 20s and 30s in China and Japan, awareness of stress’s effects on aging remain higher among health professionals.
Report shows physicians are operating in a difficult financial and mental environment.
In a recent study, restricted access to abortion and increased travel time to the nearest abortion clinic were associated with increased mental distress in women aged 18 to 44 years.
